Chronic Inflammation Is Correlated with Percentage of Body

Fat Independent of the Burden of Infection by Katayun, Vahdat et al.
Chronic Inﬂammation Is Correlated with Percentage of Body
Fat Independent of the Burden of Infection
Katayoun Vahdat,1 Fatemeh Azizi,1 Keivan Zandi,1 Majid Assadi,2 and Iraj Nabipour3,4
Abstract—The aim of this population-based study was to investigate the association of the percentage of
body fat (BF) and high-sensitivity C-reactive protein (hs-CRP) when the infectious burden was adjusted
for. A total of 1,546 subjects were randomly selected. BF was determined using bioelectrical impedance
analysis. Sera were analyzed for IgG antibodies to Chlamydia pneumoniae, herpes simplex virus type 1,
Helicobacter pylori, and cytomegalovirus using ELISA. Measurement of C-reactive protein (CRP) by a
high-sensitivity CRP assay was performed. A linear relationship between an increase in the number of
pathogens and CRP concentrations was observed (p=0.007). Age-adjusted serum hs-CRP levels were
correlated with percentage of BF in men (r=0.28, p<0.0001) and women (r=0.37, p<0.0001). In
multiple regression analyses, hs-CRP showed signiﬁcant correlations with percentage of BF after
controlling for age, sex, cardiovascular risk factors, and the infectious burden was divided into two, three,
and four pathogens [(β=0.24, p<0.0001), (β=0.2 1, p<0.0001), and (β=0.23, p=<0.0001), respectively].
In conclusion, there was a strong association between hs-CRP and percentage of body fat independent of
viral and bacterial pathogens that had been previously associated with coronary artery disease as well as
carotid atherosclerosis.
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INTRODUCTION
Recent research has pinpointed adipose tissue as an
active organ in modulating glucose and energy metab-
olism, insulin sensitivity, bone metabolism, immunity,
and inﬂammation. This dynamic endocrine tissue pro-
duces a variety of proinﬂammatory and anti-inﬂamma-
tory molecules, including leptin, adiponectin, resistin,
visfatin, monocyte chemoattractant protein 1 as well as
cytokines such as tumor necrosis factor alpha (TNF-α)
and interleukin (IL)-6 [1].
It has been proposed that adipose tissue-derived
proinﬂammatory cytokines contribute to the progression
of multiple cardiometabolic risk factors independently of
the body mass index (BMI) through production of
chronic low-grade inﬂammation [2, 3]. Numerous
studies in various parts of the world have clearly
established that the C-reactive protein (CRP), as a blood
biomarker for low-grade inﬂammation, predicts myocar-
dial infarction, coronary artery disease death, stroke,
peripheral artery disease, sudden death, etc. [4]. Thus,
the Centers for Disease Control and the American Heart
Association have issued a statement recommending that
patients at intermediate risk of coronary artery disease
might beneﬁt from measurement of CRP [5].
The direct association between adiposity and low-
grade inﬂammation has been under close investigation in
both cross-sectional [6, 7] and longitudinal studies [8, 9].
In the medical literature, the correlation between subcuta-
neous and visceral adipose tissue and markers of chronic
low-grade inﬂammation, in particular the presence of the
highly sensitive C-reactive protein (hs-CRP), is well
described [10–13]. Visceral fat thickness was reported to
be the strongest contributor to circulating hs-CRP in
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patients with vascular diseases [13]. Although little is
known about the biologic mechanisms that underlie this
association, circulating hs-CRP was proposed as a bio-
marker of the presence of dysfunctional adipose tissue that
handles the positive energy balance poorly [14]. In
contrast, adiposity, particularly visceral adipose tissue,
was suggested as a key promoter of low-grade chronic
inﬂammation [10].
Chronic viral and bacterial infections induce the
production of various proinﬂammatory cytokines, such
as TNF-α and IL-6, which lead to chronic low-grade
inﬂammation [15–17]. Although little is known about
the correlation between measures of obesity and chronic
viral and bacterial infections, the burden of infection
could be simultaneously involved with chronic low-
grade inﬂammation and obesity [18, 19]. The burden of
infection is deﬁned as the aggregate number of seropo-
sitivities of infectious pathogens to which an individual
has been exposed [20].
Both adiposity and chronic viral and bacterial
infections are sources of inﬂammatory stimuli and can
amplify inﬂammatory mediators, resulting in upregulat-
ing inﬂammatory pathways and hs-CRP production.
However, whether the presence of chronic subclinical
infections with bacterial or viral pathogens inﬂuences
the relationship between hs-CRP and adiposity has not
yet been well established. However, this knowledge
might provide useful insight into the pathophysiology of
obesity, chronic inﬂammation, and atherosclerosis.
Therefore, in a large community-based study of an
Iranian population, we investigated the association of the
percentage of body fat (BF) as a measure of adiposity
and circulating levels of hs-CRP when the infectious
burden was adjusted for in logistic regression models.
MATERIALS AND METHODS
Community Sampling
We conducted the present study as part of the Persian
Gulf Healthy Heart Study, which was a prospective
population-based cohort study begun in 2003–2004 and
based on men and women subjects aged >=25 years. The
Persian Gulf Healthy Heart Study was designed to
determine the risk factors for cardiovascular diseases
among the northern Persian Gulf population (Bushehr
and Hormozghan Provinces) and to develop community-
based interventional projects to change the lifestyles of the
population and to present the rising threat of cardiovascular
diseases in the region. The design of the present study
encompasses two major components: phase I is a cross-
sectional prevalence study of unhealthy lifestyles, ischemic
heart disease, and associated risk factors, and phase II is a
multiple interventional project for the reduction of cardio-
vascular diseases in the region.
In the present study, which is ancillary to the
Persian Gulf Healthy Heart Study, 1,546 (49.3% males
and 50.7% females) subjects were selected through a
stratiﬁed multistage design from the major ports of
Bushehr Province (an Iranian province having the
longest border on the Persian Gulf).
A fasting blood sample was taken, and all samples
were promptly centrifuged and separated. Analyses were
carried out at the Persian Gulf Health Research Center
on the day of blood collection, using a Selectra 2
autoanalyzer. Detailed information about the methods
and procedures of this study is available elsewhere [21].
Examinations
Blood pressure was assessed twice at the right arm
after a 15-min rest in the sitting position, using a
standard mercury sphygmomanometer. Height and
weight were measured using a stadiometer. Heavy outer
garments and shoes were removed before measuring
height and weight. Waist circumference was deﬁned at
the midway level between the costal margins and the
iliac crests. Hip circumference was measured at the level
of the greater trochanters. Body mass index (BMI) and
waist-to-hip ratio (WHR) were calculated. Percentage of
body fat was determined using bioelectrical impedance
analysis with the portable apparatus (OMRON BF 302,
OMRON Matsusaka Co., Ltd. Japan) with accuracy up
to 0.1%. Lukaki et al. presented the basic principles of
bioelectric impedance analysis [22].The OMRON body
fat monitor has been validated [23].
Deﬁnitions
Using American Diabetes Association criteria, a
fasting plasma glucose of 126 mg/dL or greater or the
use of antidiabetic measures was deﬁned as diabetes
[24]. The cutoff points of serum total cholesterol, high-
density lipoprotein cholesterol (HDL-C), and low-den-
sity lipoprotein cholesterol (LDL-C) distributions used
to assign subjects to different levels of risk were those
derived from the National Cholesterol Education Pro-
gram guidelines in the USA (Adult Treatment Panel III)
[25]. A subject was considered hypertensive if the blood
pressure was at least 140/90 mmHg. Respondents were
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classiﬁed as active if they reported sufﬁcient physical
activity of moderate intensity (≥30min per day ≥5 days per
week) or of vigorous intensity (≥20 min per day ≥3 days
per week). Smoking was considered to be present when the
participant smoked cigarettes or used a shisha (water pipe)
daily. The aggregate number of seropositivities to Chla-
mydia pneumoniae, Helicobacter pylori, cytomegalovirus
(CMV), or herpes simplex virus type 1 (HSV) was deﬁned
as a pathogen burden [20].
Serology
IgG antibodies againstC. pneumoniaeweremeasured
by a commercial test kit (DRG Instruments GmbH,
Germany). The principle of the kit was based on an
indirect solid-phase enzyme immunoassay with horserad-
ish peroxidase as a marker enzyme; the positivity threshold
was enzyme immunounits >45. Sera were screened for IgG
antibodies against HSV, CMV, and H. pylori with an
ELISA kit (Radim SpA, Italy), and the samples were
considered positive with IgG values higher than 30 RU/ml
for CMV and H. pylori. Samples with optical density
higher than the cutoff control were considered reactive for
anti-HSV type 1 IgG antibodies. Measurement of CRPwas
performed by a high-sensitivity CRP assay, CRP HS
ELISA (DRG International, Inc. USA). The minimum
detectable concentration of the CRP HS ELISA assay was
estimated to be 0.1 mg/l. Additionally, the functional
sensitivity was determined to be 0.1 mg/l (as determined by
inter-assay % CV <20%).
Statistical Analysis
Normal distribution of the data was controlled with
the Kolmogorov–Smirnov test. Probability values <5%
were considered statistically signiﬁcant. The signiﬁcance
of the difference in the results of any two groups was
determined by chi-square analysis using 2×2 contingen-
cy tables for categorical variables and ANOVA for
continuous variables. A two-tailed t test was used to
compare the mean values across groups. A p<0.05 was
considered statistically signiﬁcant. We found that log
transformation of hs-CRP gave a better ﬁt to a Gaussian
distribution. The geometric mean for CRP was deﬁned
as the arithmetic mean of the log-transformed data±2
SD raised to the power of 10. Multiple linear regression
models were used to assess the association between
percentage of BF, waist circumference, and waist-to-hip
ratio (independent variables) and hs-CRP levels (depen-
dent variable); each independent variable was considered
a separate independent variable in a series of models.
Age, smoking, physical inactivity, dyslipidemia, hyper-
tension, diabetes mellitus, and pathogen burden (four,
three, two pathogens versus zero to one pathogen) were
considered covariates in multiple linear regression
models.
We excluded 187 subjects with hs-CRP concentra-
tions > =10.0 mg/l from statistical analysis to omit possible
cases of acute infections and other occult diseases.
All statistical analyses were performed using the
PASW Statistics GradPack 18 (SPSS Inc., Chicago, IL).
RESULTS
A total of 1,546 (49.3% males and 50.7% females)
subjects were evaluated for the association of percentage
of BF and hs-CRP levels. Of the studied subjects, 40.7%
were between 25 and 34 years, 29.3% between 35 and
44 years, 19.2% between 45 and 54 years, and 10.8%
between 55 and 66 years. The prevalence of the
consumption of antihypertensive, hypolipidemic, and
antidiabetic drugs was 5.2%, 3.5%, and 3.8%, respec-
tively. Of the studied population, 24.1%, 48.5%, 19.2%,
20.5%, and 7.1% had hypertension, low HDL-C, high
LDL-C, hypercholesterolemia, and diabetes mellitus,
respectively.
The baseline characteristics including anthropomet-
ric information, cardiovascular risk factors, and the
prevalence of IgG antibodies against CMV, HSV, C.
pneumoniae, and H. pylori in men and women are
presented in Table 1. Women had higher percentages of
BF, BMI, waist circumference, and hs-CRP levels than
men (p<0.0001). Women also had signiﬁcantly higher
seropositivity for CMV and H. pylori but lower
seropositivity for C. pneumoniae than men (Table 1).
The prevalence of IgG antibodies against CMV,
HSV, C. pneumoniae, and H. pylori was 93.3%, 85.6%,
40.7%, and 61.3%, respectively. The prevalence of the
number of pathogens (zero to one, two, three, and four)
was 6.8%, 26.7%, 42.6%, and 23.8%, respectively.
The geometric mean levels of hs-CRP across
quartiles of percentages of BF for men and women are
shown in Figs. 1 and 2. Age-adjusted serum hs-CRP
levels were correlated with percentage of BF in men (r=
0.28, p<0.0001) and women (r=0.37, p<0.0001).
Likewise, age-adjusted circulating hs-CRP levels were
correlated with waist circumference (r=26, p<0.0001
for men and r=0.38, p<0.0001 for women) and waist-
to-hip ratio (r=0.19, p<0.0001 for men and r=0.23, p<
0.0001 for women). A linear relationship between the
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increase in the number of pathogens and CRP concen-
trations was observed (p=0.007). In women, a linear
relationship between the increase in the number of
pathogens and percentage of BF was also observed (p=
0.002). However, no such relationship could be found for
men (p>0.05).
Table 2 shows the results of multiple linear
regression analyses for the correlation between percent-
age of BF and log hs-CRP after controlling for age,
cardiovascular risk factors, and infectious burden divid-
ed into two, three, and four pathogens in men and
women. In multiple regression analyses, hs-CRP showed
signiﬁcant correlations with percentage of BF after
controlling for age, sex, cardiovascular risk factors, and
infectious burden divided into two, three, and four
pathogens [(β=0.24, p<0.0001), (β=0.2 1, p<0.0001),
and (β=0.23, p=<0.0001), respectively]. Likewise, log
hs-CRP levels were signiﬁcantly correlated with waist
circumference and waist-to-hip ratio after adjustments
for age, cardiovascular risk factors, and infectious
burden divided into two, three, and four pathogens in
both genders (Table 2).
Table 1. Clinical Characteristics and Laboratory Values of a Random Population of the Northern Persian Gulf (the Study Population)
Men (n=864) Women (n=890) p value
BMI, kg/m2 26.05 (4.64) 28.39 (5.69) <0.0001
Systolic blood pressure, mmHg 130.92 (47.47) 121.46 (23.56) <0.0001
Diastolic blood pressure, mmHg 83.71 (47.58) 77.25 (18.25) <0.0001
Total cholesterol, mg/dl 201.60 (46.42) 210.27 (48.78) <0.0001
HDL cholesterol, mg/dl 41.41 (31.34) 48.07 (42.28) <0.0001
LDL cholesterol, mg/dl 117.36 (63.38) 120.67 (50.49) <0.226
Triglyceride, mg/dl 81.06 (108.84) 160.83 (95.22) <0.0001
Fasting blood sugar, mg/dl 91.28 (36.02) 93.20 (44.18) <0.319
C-reactive protein, mg/la 1.64 (3.58) 2.33 (4.07) <0.0001
Body fat, % 24.65 (5.75) 34.09 (6.65) <0.0001
Smoking, % 36.5 21.9 <0.0001
Physical inactivity, % 68.5 73.1 0.001
Chlamydia pneumoniae, seropositive, % 45.7 35.8 <0.0001
Helicobacter pylori seropositive, % 63.2 60.2 0.109
Cytomegalovirus seropositive, % 92.1 94.3 0.045
Herpes simplex type 1 seropositive, % 83.7 88.5 0.003
Values are mean (SD), except for smoking, physical inactivity, body fat, and seropositivity to infectious markers
BMI body mass index
aGeometric mean (SD)
Fig. 1. Geometric mean (SD) of hs-CRP across quartiles of percentage
body fat (%BF) in men.
Fig. 2. Geometric mean (SD) of hs-CRP across quartiles of percentage
body fat (%BF) in women.
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DISCUSSION
In a large representative sample of the Iranian
population, we showed a strong correlation between chronic
low-grade inﬂammation and percentage of body fat,
independent of the burden of common viral and bacterial
pathogens that had been previously associated with coro-
nary artery disease as well as carotid atherosclerosis.
Bioelectrical impedance analysis (BIA), which
involves the passage of a weak current across the
extremities, is widely accepted as a simple, safe, rapid,
low-cost, and reliable technique for determining the
percentage of body fat (BF) [26]. Although BMI is a
useful index of adiposity, the percentage of BF estimated
by BIA may be superior to BMI as a surrogate measure
of BF [27]. Hence, more and more attention has been
focused on the association between the percentage of BF
and coronary artery disease risk factors, metabolic
syndrome, and dyslipidemia [26, 28].
In the current study, we found a signiﬁcant
correlation between the percentages of BF measured by
BIA and elevated hs-CRP, as a cardiovascular risk in
adults. A few studies have used measures of body fat to
investigate the association between hs-CRP and obesity
[29–32]. In monozygotic twins, CRP concentration was
strongly related to both total and central abdominal
obesity, independent of genetic inﬂuences [29]. In the
Insulin Resistance Atherosclerosis Study, measures of
body fat were strongly associated with CRP levels [31].
In another population-based study, the percentage of fat
mass explained the highest percentage of the variability
of CRP in women [30]. Lin et al. reported that the
percentage of body fat mass was strongly associated
with elevated hs-CRP levels in both genders [32].
CRP is produced by hepatocytes, and its gene
expression is predominantly regulated by two cytokines,
tumor necrosis factor-α and interleukin-6, which are
secreted by adipose tissue [33]. The major source of
white adipose tissue-produced TNF-α and 50% of white
adipose tissue-derived IL-6 are macrophages, which may
be attracted to adipose tissue by locally produced
proinﬂammatory cytokines [34]. Therefore, individuals
with a higher percentage of body fat may have higher
baseline CRP, as we observed in our study. Although
adipose tissue may contribute to chronic, low-grade
inﬂammation by triggering the inﬂammatory cascade,
chronic infections with different pathogens also stimu-
late and amplify the production of proinﬂammatory
cytokines [18]. In our study, a linear relationship
between an increase in the number of pathogens and
hs-CRP concentrations was also observed. This ﬁnding
was in accordance with a previous report that showed
not only measures of body fat but also pathogen
exposure were signiﬁcant, independent predictors of
elevated CRP in Filipino women [35]. Hence, the burden
of infection or pathogen exposure may upregulate
inﬂammatory pathways synergistically with adiposity,
resulting in elevated CRP concentrations.
On the other hand, Fernandez-Real et al. showed a
signiﬁcant association between the burden of infection
and fat mass and the percentage of fat mass [19]. They
observed a signiﬁcant linear relationship between the
number of infectious pathogens to which an individual
has been exposed and the fat mass in healthy middle-
aged men [19]. Similarly, an increased prevalence of
asymptomatic past C. pneumoniae infection in premen-
opausal obese women with body mass and percentage of
BF above median values was reported [18]. In a
multinational epidemiological study, seropositivity for
Table 2. Multiple Linear Regression Analysis for the Association be-
tween Measures of Adiposity (Percentage of Body Fat, Waist-to-hip
Ratio, Waist Circumference or Body Mass Index) and hs-CRP levels
(dependent variable) in different models
Men Women
β p β p
Percentage of body fat
Model 1 0.19 0.007 0.48 <0.0001
Model 2 0.27 <0.0001 0.32 <0.0001
Model 3 0.30 <0.0001 0.42 <0.0001
Waist-to-hip ratio
Model 1 0.19 0.017 0.26 <0.0001
Model 2 0.16 0.003 0.30 <0.0001
Model 3 0.17 0.013 0.30 <0.0001
Waist circumference
Model 1 0.20 0.008 0.41 <0.0001
Model 2 0.26 <0.0001 0.43 <0.0001
Model 3 0.25 <0.0001 0.41 <0.0001
Body mass index
Model 1 0.07 0.314 0.23 <0.0001
Model 2 0.19 <0.0001 0.34 <0.0001
Model 3 0.28 <0.0001 0.37 <0.0001
Model 1 included age, cardiovascular risk factors, and infectious
burden divided into two pathogens in addition to percentage of body
fat, waist-to-hip ratio, waist circumference or body mass index. Model 2
included percent BF, age, cardiovascular risk factors, and infectious
burden divided into three pathogens in addition to percentage of body fat,
waist-to-hip ratio, waist circumference, or body mass index. Model 3
included percentage of BF, age, cardiovascular risk factors, and infectious
burden divided into four pathogens in addition to percentage of body fat,
waist-to-hip ratio, waist circumference, or body mass index
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H. pylori and C. pneumoniae was both signiﬁcantly and
synergistically associated with overweight [36]. In
agreement with those studies, we also found a signiﬁcant
association between the burden of infection and the
percentage of BF in women. Thus, the burden of
infection or chronic infections with different pathogens
could be simultaneously associated with the percentage
of body fat and produce chronic low-grade inﬂamma-
tion. For that reason, we investigated the association
between percentage of body fat and chronic inﬂamma-
tion with regard to the pathogen burden. In other words,
since chronic infections are associated not only with
chronic inﬂammation but also with measures of obesity,
adjustment for the burden of infection seems to be
essential in logistic regression models when the rela-
tionship of chronic inﬂammation with adiposity is under
investigation.
In the current large community-based study, the
signiﬁcant association of the percentage of body fat with
circulating levels of hs-CRP persisted when the infec-
tious burden was adjusted for. In other words, the
percentage of BF is associated with chronic low-grade
inﬂammation, independent of the burden of common
viral and bacterial infections. These results were in
agreement with previous results showing that obesity, as
measured by the percentage of BF, was a low-grade
inﬂammatory state. Chronic low-grade inﬂammation
(elevated CRP levels) was suggested as a marker of the
presence of dysfunctional adipose tissue originating
from an obesogenic lifestyle [14]. However, the ultimate
reason for increased production of TNF-α and IL-6 by
adipose tissue, and the resulting synthesis of CRP by the
liver, has not been identiﬁed.
Intra-abdominal adipose tissue mass, assessed with
computed tomography, showed a signiﬁcant association
with circulating CRP [10, 11]. Waist circumference and
WHR have been the traditional anthropometric indices
for assessing central obesity. Waist circumference was
signiﬁcantly associated with circulating CRP levels in
different studies [10, 37, 38]. Our multivariate analyses
demonstrated that waist circumference and WHR also
had a signiﬁcant association with hs-CRP levels,
independent of the viral and bacterial infectious burden.
The northern Persian Gulf is classed as a middle-
income region from socioeconomic view. However,
more than half of men and women aged ≥25 years in
this region have unhealthy body weight (BMI>25 or
central obesity) [39]. Although more than 86% in rural
areas to 100% in urban areas of this region could have
access to Primary Health Care Network and a signiﬁcant
improvement in the primary health indices was obtained,
we previously reported a high prevalence of unhealthy
lifestyle patterns for cardiovascular diseases, metabolic
syndrome, and type 2 diabetes among the northern
Persian Gulf population [21, 39, 40]. The observed
signiﬁcant discordance between prevalence of chronic
diseases and medication consumption in the current
study indicates that the overall health system perfor-
mance in the northern Persian Gulf region is low. Hence,
more preventive strategic programs are warranted to
combat the epidemic of obesity and other cardiovascular
risk factors in this region.
This study has several limitations. First, a causal
relationship between chronic low-grade inﬂammation
and adiposity could not be clariﬁed in our cross-
sectional study. Second, the use of BIA as an alternative
to dual-energy X-ray absorptiometry, which is a newer
method for estimating body composition, in overweight
and obese populations may have some limitations [41].
Third, since we assessed circulating hs-CRP levels with
single measurements, the changes in this acute phase
reactant over time could not be reﬂected in the current
study. Furthermore, the measurement of additional
inﬂammatory markers and cytokines merits consider-
ation in order to elucidate the complex system that
regulates adipose tissue, the immune system, and
inﬂammation. Fourth, we conducted our study in a large
random population and used seropositivity as a marker
for infections. Although it has the advantage of
clinical applicability, the assessment of infection
status based on serology without further clinical or
laboratory characterization is subject to diagnostic
inaccuracies, especially if seropositivity is common
because of the widespread distribution of the incriminated
microorganism [42]. In our study, the presence of
seropositivity in other confounding viral or bacterial
pathogens cannot be ruled out.
In conclusion, there is a strong association between
circulating hs-CRP levels and the percentage of BF
independent of the viral and bacterial infectious burden
in a healthy population. Although it is difﬁcult to
conclude whether body fat induces low-grade inﬂamma-
tion or is a consequence of it, a strong association of hs-
CRP levels and body fat independent of chronic
infections is a promising breakthrough. Furthermore,
since chronic low-grade inﬂammation has been shown to
be a predictor of cardiovascular disease, it can be
hypothesized that the contribution of body fat to chronic
inﬂammation may be related to the risk of cardiovascular
events. Therefore, a reduction in body fat percentage
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may prevent the elevation of acute-phase reactants and
cytokine levels as well as cardiovascular disease.
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